Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)
Clinical trial NCT01573338 · TERMINATED
Trial details
- NCT number
- NCT01573338
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-25
- Primary completion
- 2016-03-25
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.